Molecular and Systems Pharmacology Program, Laney Graduate School, Emory University, Atlanta, GA, United States.
Center for the Study of Human Health, Emory University College of Arts and Sciences, Atlanta, GA, United States; Department of Dermatology, Emory University School of Medicine, Atlanta, GA, United States; Antibiotic Resistance Center, Emory University, Atlanta, GA, United States; Emory University Herbarium, Atlanta, GA, United States.
Curr Opin Microbiol. 2018 Oct;45:189-194. doi: 10.1016/j.mib.2018.08.004. Epub 2018 Sep 13.
The continued spread of antimicrobial resistance represents one of the most serious infectious disease threats to global health. There is consensus that a key component of addressing this threat is to replenish the waning pipeline of antimicrobials, with attention being paid to novel mechanisms of action. This includes the development of new classes of classic bacteriostatic and bactericidal antibiotics as well as antivirulence drugs, and it is especially in these areas where plant natural products demonstrate great potential. To this end, we discuss the unique characteristics of plant natural products, the advantages of plants as a resource for anti-infective drug discovery, and recent technologies that have further enabled this path of inquiry. As a result of emerging realization of their advantages, plant natural products have recently enjoyed increased scrutiny in antimicrobial lead discovery, and they will continue to serve as a source of leads. We conclude that plant natural products represent a promising and largely untapped source of new chemical entities from which novel anti-infectives can be discovered.
抗菌药物耐药性的持续传播是对全球健康构成的最严重传染病威胁之一。人们普遍认为,应对这一威胁的一个关键组成部分是补充日益减少的抗菌药物管线,同时关注新型作用机制。这包括开发新型经典抑菌和杀菌抗生素以及抗毒药物,而植物天然产物在这些领域具有巨大的潜力。为此,我们讨论了植物天然产物的独特特征、植物作为抗感染药物发现资源的优势,以及最近进一步推动这一研究途径的技术。由于人们越来越认识到它们的优势,植物天然产物在抗菌先导化合物发现中最近受到了更多的关注,并且它们将继续作为先导化合物的来源。我们的结论是,植物天然产物代表了一种有前途且尚未充分开发的新型化学实体来源,可以从中发现新型抗感染药物。